Product Information
IVABRADINE HCL 5 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.7713 per EA under NDC 70710147106. Its NADAC has been published 88 times since Oct 23, 2024.
Strength
5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710147106
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213442On Market Since
7/2/2024
Pharmacological Classes
Price Statistics
The NADAC for IVABRADINE HCL 5 MG TABLET has been published 88 times since Oct 23, 2024, and over the history we have for it it has declined 83.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7713 per EA |
|---|---|
| All-time high | $4.5638 (Nov 13, 2024) |
| All-time low | $0.7713 (Jun 17, 2026) |
| 52-week high | $3.1866 |
| 52-week low | $0.7713 |
| Median price | $3.0340 |
| Average price | $2.7854 |
| Largest weekly change | -40.9% (Feb 18, 2026) |
| Weeks tracked | 88 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IVABRADINE HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 5 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.7713 per EA (NDC 70710147106), effective Jun 24, 2026.
How has the price of IVABRADINE HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for IVABRADINE HCL 5 MG TABLET has declined 83.1%. It has been tracked across 88 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 5 MG TABLET?
Since Oct 23, 2024, the NADAC for IVABRADINE HCL 5 MG TABLET has ranged from a low of $0.7713 (Jun 17, 2026) to a high of $4.5638 (Nov 13, 2024), with a median of $3.0340 per EA.
Are there cheaper alternatives to IVABRADINE HCL 5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as IVABRADINE HCL 5 MG TABLET, but none are currently priced below it.
Who manufactures IVABRADINE HCL 5 MG TABLET?
IVABRADINE HCL 5 MG TABLET (NDC 70710147106) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification